Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WUBA
58.com Inc
WUBA
|
+$198M |
| 2 |
Stellantis
STLA
|
+$166M |
| 3 |
Shopify
SHOP
|
+$95.9M |
| 4 |
ICICI Bank
IBN
|
+$66M |
| 5 |
Itaú Unibanco
ITUB
|
+$62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NBIS
Nebius Group N.V.
NBIS
|
+$429M |
| 2 |
Amazon
AMZN
|
+$333M |
| 3 |
MBLY
Mobileye N.V.
MBLY
|
+$322M |
| 4 |
Alibaba
BABA
|
+$277M |
| 5 |
Qiagen
QGEN
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 37.3% |
| 2 | Communication Services | 18.48% |
| 3 | Healthcare | 13.51% |
| 4 | Technology | 8.97% |
| 5 | Financials | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Pacira BioSciences
PCRX
$1.04B
| $12M | 0.02% |
320,582
+19,582
| +7% | +$788K |
|
|
STMP
152
DELISTED
Stamps.com, Inc.
STMP
| $11.8M | 0.01% |
58,048
-7,202
| -11% | -$1.32M |
|
|
VAR
153
DELISTED
Varian Medical Systems, Inc.
VAR
| $11.7M | 0.01% |
117,375
+16,708
| +17% | +$1.71M |
|
154
British American Tobacco
BTI
$131B
| $11.7M | 0.01% |
+187,548
| New | +$12.1M |
|
|
ADAP
155
DELISTED
Adaptimmune Therapeutics
ADAP
| $11.3M | 0.01% |
1,379,304
+55,996
| +4% | +$350K |
|
|
BCRH
156
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
| $10.4M | 0.01% |
629,438
| – | – |
|
|
AFT
157
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
| $10.3M | 0.01% |
617,746
| – | – |
|
|
FMI
158
DELISTED
Foundation Medicine, Inc.
FMI
| $10.3M | 0.01% |
255,790
+7,490
| +3% | +$289K |
|
159
Teladoc Health
TDOC
$1.22B
| $10.1M | 0.01% |
306,012
+21,012
| +7% | +$689K |
|
160
Weibo
WB
$2B
| $10.1M | 0.01% |
102,038
-11,059
| -10% | -$974K |
|
161
Codexis
CDXS
$151M
| $9.83M | 0.01% |
1,478,097
+16,684
| +1% | +$92.4K |
|
162
Digimarc Corp
DMRC
$147M
| $9.57M | 0.01% |
261,462
+8,564
| +3% | +$267K |
|
163
Stratasys
SSYS
$679M
| $9.33M | 0.01% |
403,505
+25,705
| +7% | +$594K |
|
|
FARO
164
DELISTED
Faro Technologies
FARO
| $8.74M | 0.01% |
228,404
+10,424
| +5% | +$377K |
|
165
STAAR Surgical
STAA
$1.21B
| $8.7M | 0.01% |
698,742
+32,130
| +5% | +$358K |
|
166
Ambarella
AMBA
$3.77B
| $8.67M | 0.01% |
176,999
+56,899
| +47% | +$2.81M |
|
167
SLB Ltd
SLB
$73.6B
| $8.31M | 0.01% |
119,127
| – | – |
|
|
ONC
168
BeOne Medicines Ltd
ONC
$32.8B
| $8.28M | 0.01% |
80,010
+5,586
| +8% | +$416K |
|
169
CEVA Inc
CEVA
$910M
| $8.27M | 0.01% |
193,198
+9,798
| +5% | +$423K |
|
|
NCNA
170
NuCana
NCNA
$5.49M
| $8.27M | 0.01% |
+90
| New | +$7.77M |
|
|
BNFT
171
DELISTED
Benefitfocus, Inc.
BNFT
| $8.04M | 0.01% |
+238,850
| New | +$7.65M |
|
172
Microchip Technology
MCHP
$40.3B
| $7.42M | 0.01% |
165,320
| – | – |
|
|
HIMX
173
Himax Technologies
HIMX
$2.19B
| $7.39M | 0.01% |
675,800
| – | – |
|
|
MB
174
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $6.88M | 0.01% |
266,264
+15,603
| +6% | +$387K |
|
|
LTRPA
175
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $6.71M | 0.01% |
543,314
| – | – |
|
Similar funds
Baillie Gifford & Co's Q3 2017 Portfolio in Review
As of Q3 2017, Baillie Gifford & Co held 209 positions worth $79B, up 6.3% from $74.3B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Baillie Gifford & Co withdrew a net $3.29B in Q3 2017, closing 11 positions and reducing 88 holdings. Its most notable exit was Qiagen, an estimated $240M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 37% of assets, down from 38% a quarter earlier, followed by Communication Services and Healthcare.
Against the trend, Baillie Gifford & Co opened a new position in Shopify worth $109M.
- Baillie Gifford & Co's largest Q3 2017 buy was Shopify: 9,386,610 shares worth $109M.
- Baillie Gifford & Co added most to 58.com Inc in Q3 2017, an estimated $198M increase.
- Baillie Gifford & Co's biggest Q3 2017 reduction was Nebius Group N.V., cutting an estimated $429M.
- Baillie Gifford & Co fully exited Qiagen in Q3 2017, selling an estimated $240M.
- Baillie Gifford & Co's ten largest holdings make up 52% of its $79B portfolio in Q3 2017.
- Baillie Gifford & Co opened 8 new positions and closed 11 in Q3 2017.
- Baillie Gifford & Co's portfolio value rose 6.3% quarter-over-quarter to $79B.
Based on Baillie Gifford & Co's 13F filing for Q3 2017, filed 20 Oct 2017.